NT
Therapeutic Areas
Nephronomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Nephronomics Atlas Discovery | Cardio-Kidney-Metabolic (CKM) Disease Subtyping & Target ID | Discovery |
Leadership Team at Nephronomics
JW
Jan Walter, MBA
Founder & Acting CEO
DK
Deniz Kural, PhD
Founder & CSO
BH
Benjamin Hippen, MD
Founder & Acting CMO
JS
James Sietstra
Founder & Board Member
MS
Michael Strömberg, PhD
Head of Data Science and Bioinformatics
EG
Eric Green, MD, PhD
Scientific Advisor
FM
Franklin Maddux, MD
Scientific Advisor